Sirolimus use in liver transplant recipients with hepatocellular carcinoma: A randomized, multi-centre, open-label phase 3 trial – The SiLVER-study. (April 2016) - Schnitzbauer, A.; Schlitt, H.J.; Geissler, E.K.; ,